US FDA approves French drugmaker Ipsen’s rare bone disorder drug
By Bhanvi Satija and Sriparna Roy (Reuters) -The U.S. Food and Drug Administration (FDA) on Wednesday approved French drugmaker Ipsen’s…
2023
Cisco touts market share wins, AI potential as revenue forecast disappoints
(Reuters) -Networking equipment maker Cisco Systems’ CEO talked up market share wins and artificial intelligence (AI) opportunities, as he moved…
Wall Street ends lower after Fed minutes cloud outlook for rates
By Saeed Azhar and Noel Randewich NEW YORK (Reuters) – Wall Street ended lower on Wednesday after the Federal Reserve’s…
US CLOs’ credit profiles resilient despite mid-sized company risk -Moody’s
By Matt Tracy WASHINGTON (Reuters) – The credit quality of U.S. middle market collateralized loan obligations (CLOs), major sources of…
Exclusive-ArcelorMittal weighs possible bid for US Steel -sources
By Greg Roumeliotis and Emma-Victoria Farr (Reuters) -ArcelorMittal SA, the world’s second-largest steelmaker, is considering a potential offer for U.S….
Marketmind: Dollar, US yields deliver one-two punch
By Jamie McGeever (Reuters) – A look at the day ahead in Asian markets from Jamie McGeever, financial markets columnist….
Argentines rush to dollar safety as election uncertainty looms
By Walter Bianchi, Jorge Otaola and Lucinda Elliott BUENOS AIRES (Reuters) – Confidence in Argentina’s peso plumbed new depths on…
Fed officials divided in July over need for more rate hikes, minutes show
By Howard Schneider and Michael S. Derby WASHINGTON (Reuters) -Federal Reserve officials were divided over the need for more interest…
Optimism emerges among Hollywood writers over talks with studios
By Danielle Broadway LOS ANGELES (Reuters) – After three months of walking the picket lines, striking Hollywood writers expressed optimism…
H&M probes alleged Myanmar factory abuses as pressure intensifies
By Helen Reid LONDON (Reuters) -H&M is investigating 20 alleged instances of labour abuse at Myanmar garment factories that supply…